FSAD - Women’s Health Study

A Phase 2b, Multi-Center, Multiple-Dose, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy And Safety Of Sildenafil Cream, 3.6% In Premenopausal Patients With Female Sexual Arousal Disorder (FSAD)

woman in bed with covers


AGE: Premenopausal women, 21 +
GENDER: Female
TYPE: Interventional Treatment Study
CONDITION: Female Sexual Arousal Disorder
DEPARTMENT: Obstetrics & Gynecology
LOCATION: UH Cleveland Medical Center

Learn More About This Research Study

Please contact the MacDonald Clinical Trials Unit referral line at 440-995-3810 or fill out the form below to learn more about this study.

Study Purpose

The purpose of this study is to find out if the investigational drug, topical Sildenafil Cream, 3.6%, increases genital arousal in women during sexual activity.

Who Can Participate

Women 18 years and older who may be experiencing female sexual arousal disorder may be eligible for this study. There are certain requirements that must be met to participate in the study for both you and your partner. Your partner will need to be available throughout your participation in the study and must meet certain criteria to participate in the study. If your partner does not meet these criteria, you also will not be eligible to participate.

Request More Information

To learn more about this study, please fill out the form below to request more information.